Routine Pathologic Examination of Femoral Head Specimens from Total Hip Arthroplasty May Not Be Indicated or Cost-effective: A Systematic Review
- PMID: 35774889
- PMCID: PMC9237275
- DOI: 10.1016/j.artd.2022.03.016
Routine Pathologic Examination of Femoral Head Specimens from Total Hip Arthroplasty May Not Be Indicated or Cost-effective: A Systematic Review
Abstract
Background: There is considerable disparity in institutional practices surrounding routine pathologic examination of femoral heads removed during total hip arthroplasty (THA). Multiple groups have studied the merits of routine femoral head pathology in THA, without clear consensus. We sought to further investigate the existing evidence on routine pathologic examination of femoral heads retrieved during THA to determine if this practice provides additional clinical value and is cost-effective.
Material and methods: To conduct a systematic review of the literature, a medical librarian was consulted to develop and perform comprehensive searches in PubMed (1809-present), Embase (embase.com 1974-present), CINAHL (EBSCO, 1937-present), and the Cochrane Central Register of Controlled Trials (Wiley). Final searches resulted in 727 references. Through multiple reviewer screenings and assessments of eligible full-text articles, we included 14 articles for review.
Results: Our systematic review yielded pathologic examination results from 17,388 femoral head specimens collected during THA. In 0.85% of cases, the pathologic diagnosis differed in a meaningful way from the preoperative clinical diagnosis. Routine pathology changed patient management in approximately 0.0058% of cases. The average cost for pathologic examination of each specimen was $126.38.
Conclusion: Routine pathologic examination of femoral heads retrieved during THA has limited impact on patient management. With an estimated 500,000 THAs performed in 2019, the economic feasibility of routine femoral head pathology is limited at an annual cost of up to $63,000,000 and cost per quality-adjusted life-year approaching infinity. However, surgeon discretion on a patient-specific or practice-specific basis should be used to make the final determination on the need for femoral head pathology.
Keywords: Arthroplasty; Cost; Femoral head; Hip; Pathology; Routine.
Similar articles
-
Routine Pathologic Examination of the Femoral Head in Total Hip Arthroplasty: A Survey Study of the American Association of Hip and Knee Surgeons.Arthroplast Today. 2023 Jan 14;19:101079. doi: 10.1016/j.artd.2022.101079. eCollection 2023 Feb. Arthroplast Today. 2023. PMID: 36691462 Free PMC article.
-
Unsuspected Malignancies in Routine Femoral Head Histopathologic Examination During Primary Total Hip Arthroplasty: Cost-Effectiveness Analysis.J Arthroplasty. 2017 Mar;32(3):735-742. doi: 10.1016/j.arth.2016.08.017. Epub 2016 Aug 24. J Arthroplasty. 2017. PMID: 27697361
-
Evaluation of the Cost Effectiveness of Routine Histopathologic Femoral Head Analysis in Hip Arthroplasty.Hip Pelvis. 2022 Mar;34(1):56-61. doi: 10.5371/hp.2022.34.1.56. Epub 2022 Mar 7. Hip Pelvis. 2022. PMID: 35355630 Free PMC article.
-
Is Oxidized Zirconium Femoral Head Superior to Other Bearing Types in Total Hip Arthroplasty? A Systematic Review and Meta-Analysis.J Arthroplasty. 2019 Aug;34(8):1844-1852. doi: 10.1016/j.arth.2019.03.072. Epub 2019 Apr 2. J Arthroplasty. 2019. PMID: 31010775
-
What Is the Impact of a Previous Femoral Osteotomy on THA? A Systematic Review.Clin Orthop Relat Res. 2019 May;477(5):1176-1187. doi: 10.1097/CORR.0000000000000659. Clin Orthop Relat Res. 2019. PMID: 30998636 Free PMC article.
Cited by
-
Routine Pathologic Examination of the Femoral Head in Total Hip Arthroplasty: A Survey Study of the American Association of Hip and Knee Surgeons.Arthroplast Today. 2023 Jan 14;19:101079. doi: 10.1016/j.artd.2022.101079. eCollection 2023 Feb. Arthroplast Today. 2023. PMID: 36691462 Free PMC article.
-
Routine histopathological examination of femoral heads and incidental metastatic bone disease in hip arthroplasty.Acta Orthop Traumatol Turc. 2025 Mar 17;59(1):58-62. doi: 10.5152/j.aott.2025.24021. Acta Orthop Traumatol Turc. 2025. PMID: 40337985 Free PMC article.
-
Routine Pathologic Examination of Femoral Heads is Not Warranted.Arthroplast Today. 2025 Jan 23;31:101624. doi: 10.1016/j.artd.2025.101624. eCollection 2025 Feb. Arthroplast Today. 2025. PMID: 39927122 Free PMC article. No abstract available.
-
Routine Histopathologic Examination of Bone Obtained During Elective Primary Total Knee Arthroplasty May Not Be Necessary.Arthroplast Today. 2023 Sep 18;23:101200. doi: 10.1016/j.artd.2023.101200. eCollection 2023 Oct. Arthroplast Today. 2023. PMID: 37745964 Free PMC article.
-
Femoral Head Pathology in Subcapital Hip Fractures: Clinical Value and Cost-Effectiveness in a 230-Patient Case Series.Diagnostics (Basel). 2025 Jan 20;15(2):234. doi: 10.3390/diagnostics15020234. Diagnostics (Basel). 2025. PMID: 39857118 Free PMC article.
References
-
- Singh J.A., Yu S., Chen L., Cleveland J.D. Rates of total joint replacement in the United States: future projections to 2020-2040 using the National Inpatient Sample. J Rheumatol. 2019;46:1134–1140. - PubMed
-
- Sloan M., Premkumar A., Sheth N.P. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100:1455–1460. - PubMed
-
- Pivec R., Johnson A.J., Mears S.C., et al. Hip arthroplasty. Lancet. 2012;380:1768–1777. - PubMed
-
- Kocher M.S., Erens G., Thornhill T.S., et al. Cost and effectiveness of routine pathological examination of operative specimens obtained during primary total hip and knee replacement in patients with osteoarthritis. J Bone Joint Surg Am. 2000;82:1531–1535. - PubMed
LinkOut - more resources
Full Text Sources
